Clinical Edge Journal Scan

Clinical Edge Journal Scan

Breast cancer: Etoricoxib reduces taxane-associated acute pain syndrome

Publish date: July 27, 2022

Read More

Clinical Edge Journal Scan

HER2-negative metastatic BC: First-line nivolumab, bevacizumab, paclitaxel shows promise in phase 2

Publish date: July 27, 2022

Read More

Clinical Edge Journal Scan

Concurrent use of DOAC and tamoxifen does not increase hemorrhage risk in BC

Publish date: July 27, 2022

Read More

Clinical Edge Journal Scan

DBT lowers risk for advanced BC diagnosis in women with dense breasts and at high risk

Publish date: July 27, 2022

Read More

Clinical Edge Journal Scan

HER2-low metastatic BC: Phase 3 establishes trastuzumab deruxtecan as a new standard-of-care

Publish date: July 27, 2022

Read More

Clinical Edge Journal Scan

Commentary: Treating ER+ Breast Cancer and Brain Metastases, July 2022

Author:: Ajay Dhakal MBBS

Publish date: July 6, 2022

Read More

Clinical Edge Journal Scan

Commentary: New Horizons in NSCLC Treatment: Adagrasib, Aumolertinib, and Lorlatinib, July 2022

Author:: Jonathan W. Riess, MD, MS

Publish date: July 1, 2022

Read More

Clinical Edge Journal Scan

Commentary: Ramucimumab, Napabucasin, and Pembrolizumab Trial Results, July 2022

Author:: Nataliya Uboha, MD, PhD

Publish date: July 1, 2022

Read More

Clinical Edge Journal Scan

Commentary: Recent Chemotherapy Regimen Trial Results, July 2022

Author:: Thomas Abrams, MD

Publish date: July 1, 2022

Read More

Clinical Edge Journal Scan

ER+/HER2− BC: Age and Ki-67 index predict nodal response to NAC

Publish date: June 23, 2022

Read More

Clinical Edge Journal Scan

Similar prognosis in pregnant vs. nonpregnant BC patients receiving chemotherapy

Publish date: June 23, 2022

Read More

Pages